Page last updated: 2024-10-29

iohexol and Day Blindness

iohexol has been researched along with Day Blindness in 3 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frontera, JA1
Pile-Spellman, J1
Mohr, JP1
Levorstad, K2
Simonsen, S2
Jervell, J1
Skrede, M1
Orning, O1
Tylén, U1
Olsson, L1
Selin, K1
Dahlström, K1
Andrew, E1

Trials

2 trials available for iohexol and Day Blindness

ArticleYear
Tolerability and usefulness of iohexol in cardioangiography. II. A double blind comparison with metrizoate.
    Acta radiologica. Supplementum, 1983, Volume: 366

    Topics: Adult; Aged; Angiocardiography; Clinical Trials as Topic; Contrast Media; Double-Blind Method; Drug

1983
Tolerability and usefulness of iohexol in cardioangiography. I. An open multicentre clinical trial.
    Acta radiologica: diagnosis, 1982, Volume: 23, Issue:6

    Topics: Adult; Aged; Angiocardiography; Blood Pressure; Clinical Trials as Topic; Contrast Media; Electrocar

1982

Other Studies

1 other study available for iohexol and Day Blindness

ArticleYear
Contrast-induced neurotoxicity and selective cortical injury.
    Cerebrovascular diseases (Basel, Switzerland), 2007, Volume: 24, Issue:1

    Topics: Angiography, Digital Subtraction; Carotid Artery, Common; Cerebral Cortex; Contrast Media; Diffusion

2007